Clinical Trials Directory

Trials / Completed

CompletedNCT00821236

Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK

A Prospective, Multi Center Clinical Comparison of Fellow Eyes Undergoing Lasik Using the Wavelight Allegretto Wave™ Excimer Laser in One Eye and the Amo/Visx Customvue™ or the Ladarvision 4000 Excimer Laser System in the Contralateral Eye

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Durrie Vision · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare LASIK outcomes using the WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment. Standard refractive outcomes such as uncorrected and best corrected visual acuity, and intended vs. achieved postoperative refractions will be evaluated; in addition, high order optical aberrations, contrast sensitivity, and topography will be measured.

Detailed description

The primary objective of this study is to compare WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment using both subjective and objective outcome measures. This comparison will be made between fellow eyes of the same patient following excimer laser ablation using the WaveLight ALLEGRETTO WAVE™ Excimer Laser System in one eye and the AMO/VISX CustomVue™ or the LADARVision 4000 excimer laser in the contralateral eye .

Conditions

Interventions

TypeNameDescription
DEVICEExcimer LaserWaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment
DEVICEAMO/VISX CustomVue™Excimer Laser
DEVICELADARVision 4000 excimer laserExcimer Laser

Timeline

Start date
2009-01-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2009-01-13
Last updated
2013-03-01
Results posted
2013-03-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00821236. Inclusion in this directory is not an endorsement.